News

Pipeline Therapeutics Completes $80 Million Series C Financing

​

Turnstone Biologics Acquires Novel Cell Therapy Platform

​

GrubMarket raises $60M as food delivery stays center stage

​

GrubMarket Raised $90 Million in 2020

​

Turnstone Biologics Announces First Patients in Phase 1/2 Clinical Trial for RIVAL-01

​

Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases

​

Antios Therapeutics Completes Phase 1b Trial for Hepatitis B Virus

​

Antios Therapeutics Appoints Gregory T. Mayes Chief Executive Officer

​

Veem Secures $31M in Strategic Funding Round

​